| |
|
ASCIA MEMBER GRANTS 2004 - 2009 |
| 2009 |
| ASCIA / Schering Plough respiratory allergy grants |
| |
|
Allergy to subtropical grass pollens in Australia;
IgE cross-reactivity between subtropical and temperate grass pollens
|
| Dr Janet Davies and Prof John Upham |
|
School of Medicine, PAH, University of Queensland
|
|
|
Replication study of genetic predisposition of KIR2DL4 alleles to asthma
|
| A/Prof Campbell Witt(1), Prof Patrick Holt(2), Prof Frank Christiansen(1) |
| 1 Dept Clinical Immunology and Immunogenetics, PathWest, Royal Perth Hospital, WA |
|
2 Institute of Child Health Research, WA
|
|
|
| |
| 2008 |
|
ASCIA / GSK respiratory allergy grants
|
|
| Australian Pollen Immunotherapy study |
| Dr Tiffany Hughes |
| Princess Margaret Hospital, WA |
|
| Purchase of a TSI 8220 Particle Counter to measure exposure to allergens during sleep |
| Dr Euan Tovey and Dr Janet Rimmer |
| Woolcock Institute of Medical Research, NSW |
|
| |
|
2007
|
| In 2007 ASCIA provided grants worth a total of $110,000 (AUD) including $50,000 (AUD) provided by CSL BIOTHERAPIES for anaphylaxis related projects. |
| |
| Effects of statins on the migration and apoptosis of dendritic cells |
| Prof Philip Thompson et al, WA |
| The impact of cofactor and effector cell function in CVID |
| Dr Rob Stirling et al, VIC |
| Evaluation of patient antibody responses to beta2microglobulin in relation to lupus anticoagulant and anti-cardiolipin results |
| Dr Christine Bundell et al, WA |
| |
|
2007 CSL GRANTS
|
| Establishment of a national food allergy database |
| A/Prof Rohan Ameratunga et al, NZ |
| A study of the use of Intravenous promethazine for anaphylaxis |
| Prof Simon Brown et al, WA |
| Identification of patients with 18Q21.3 deletions and anaphylaxis |
| A/Prof Pete Smith, QLD |
| |
| |
|
2006
|
|
ASCIA - Antibody Deficiency Allele (ADA) Pilot Study
|
|
Dr Matthew Cook et al, ACT
|
|
ASCIA PID Register (3rd year of 3 year seed funding)
|
|
Dr Sean Riminton, Philippa Kirkpatrick, NSW
|
|
Evaluation of the risk of anaphylaxis in currently and
|
|
previously peanut allergic children advised to avoid
|
|
peanut vs those advised to regularly consume peanut
|
|
Dr Brynn Wainstein, A/Prof John Ziegler, NSW
|
|
Fatal anaphylaxis in New Zealand:
|
|
case finding for the decade 1995-2004 (seed funding)
|
|
Dr Marianne Empson, Dr Penny Fitzharris, Dr Jan Sinclair, NZ
|
|
Identification of novel gene defects in Common Variable
|
|
Immune Deficiency (CVID): a multi-centre study
|
|
A/Prof Rohan Ameratunga et al, NZ
|
| |
| |
|
2005
|
| ASCIA PID Register (2nd year of seed funding) |
|
Dr Sean Riminton, Philippa Kirkpatrick, NSW
|
| Establishing a diagnostic framework for anaphylaxis to native Australian ant venoms (continuation) |
| Prof Simon Brown, WA |
| Application to ASCIA to fund the purchase, establishment and validation of a novel device (Rhinolux) to non-invasively measure nasal congestion |
| Prof Connie Katelaris & Dr Janet Rimmer, NSW |
| A qualitative study of the needs of individuals with primary immunodeficiency disorders in transition from paediatric to adult care. |
| A/Prof Jo Douglass et al, VIC |
| Establishment of an ASCIA Anaphylaxis Registry (seed funding) |
| Dr Rob Loblay, NSW and Dr Mike Gold, SA |
| |
| |
|
2004
|
| ASCIA PID Register (seed funding) |
| Dr Sean Riminton, NSW |
| Establishing a diagnostic framework for anaphylaxis to native Australian ant venoms |
| Prof Simon Brown, WA |
